Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis
NCT ID: NCT01273779
Last Updated: 2012-02-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
PHASE2/PHASE3
1280 participants
INTERVENTIONAL
2011-06-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy Study of Recombinant Human Lactoferrin to Treat Severe Sepsis
NCT00630656
A Phase 2 Study Evaluating Efficacy, Safety and Tolerability of Different Doses and Regimens of Allocetra-OTS for the Treatment of Organ Failure in Adult Sepsis Patients
NCT04612413
Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis
NCT01739361
German Lactat Clearance in Severe Sepsis
NCT01929772
Alpha-lipoic Acid in Critically Ill Patients With Sepsis
NCT06661993
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Placebo
15 mL of oral solution of placebo given 3 times a day for up to 28 days or until discharge from the intensive care unit
Talactoferrin alfa
Talactoferrin alfa
15 mL of an oral solution of 100mg/mL (1.5 g) given 3 times a day for up to 28 days or until discharge from the intensive care unit
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Talactoferrin alfa
15 mL of an oral solution of 100mg/mL (1.5 g) given 3 times a day for up to 28 days or until discharge from the intensive care unit
Placebo
15 mL of oral solution of placebo given 3 times a day for up to 28 days or until discharge from the intensive care unit
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Onset of severe sepsis within the previous 24 hours
* Must be receiving antibiotic therapy
* Informed consent form signed by patient or authorized representatives according to local rules or regulations
* Able to take liquid medication by mouth or feeding tube
Exclusion Criteria
* Pregnant or breast-feeding
* Severe congestive heart failure
* Known severe HIV infection
* Presence of severe burns
* Patients on high dose immunosuppressants
* Patients whose death is considered imminent
* Patients whose life expectancy for concurrent illness is less than 6 months
* Severe hypoxic encephalopathy or persistent vegetative state
* Severe liver disease
* Chronically bed bound
* Patient, legal representative or patient's primary physician not committed to providing full, aggressive life support
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Agennix
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama - Birmingham
Birmingham, Alabama, United States
Providence Hospital
Mobile, Alabama, United States
Maricopa Medical Center
Maricopa, Arizona, United States
St. Joseph Hospital
Orange, California, United States
Sharp Memorial Hospital
San Diego, California, United States
Stanford University Hospital
Stanford, California, United States
UCLA Medical Center
Sylmar, California, United States
Denver Health Medical Center
Denver, Colorado, United States
Christiana Care Health Services
Newark, Delaware, United States
George Washington University Hospital
Washington D.C., District of Columbia, United States
Bay Area Chest Physicians
Clearwater, Florida, United States
Eastern Idaho Medical Consultants
Idaho Falls, Idaho, United States
West Suburban Hospital Medical Center
Oak Park, Illinois, United States
Peoria Pulmonary Associates
Peoria, Illinois, United States
Methodist Research Institute
Indianapolis, Indiana, United States
University of Iowa
Iowa City, Iowa, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Baystate Medical Center
Springfield, Massachusetts, United States
Henry Ford Hospital
Detroit, Michigan, United States
St. Johns Mercy Medical Center
St Louis, Missouri, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Cooper University Hospital
Camden, New Jersey, United States
Moses Cone Memorial Hospital
Greensboro, North Carolina, United States
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States
Riverside Methodist Hospital
Columbus, Ohio, United States
St. Vincent Mercy Medical Center
Toledo, Ohio, United States
University of Oklahoma Health Science Center
Oklahoma City, Oklahoma, United States
Cancer Institute, Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Rhode Island Hospital
Providence, Rhode Island, United States
University of Tennessee
Memphis, Tennessee, United States
Texas Tech Health Science Center
El Paso, Texas, United States
Baylor College of Medicine
Houston, Texas, United States
LDS Hospital
Murray, Utah, United States
University of Wisconsin Medical School
Madison, Wisconsin, United States
Clinique Saint-Pierre
Ottignies, Ottignies, Belgium
Hôpitaux IRIS Sud
Brussels, , Belgium
Hôpital Erasme
Brussels, , Belgium
UZ Brussel
Brussels, , Belgium
Cliniques Universitaires Saint-Luc
Brussels, , Belgium
Ziekenhuis Oost-Limburg
Genk, , Belgium
UZ Gent
Ghent, , Belgium
CHU de Liège
Liège, , Belgium
Centre Hospitalier de Dinant
Mons, , Belgium
Cliniques Universitaires UCL de Mont-Godinne
Yvoir, , Belgium
Vancouver General Hospital
Vancouver, British Columbia, Canada
Royal Jubilee Hospital
Victoria, British Columbia, Canada
St. Boniface General Hospital
Winnipeg, Manitoba, Canada
Health Sciences Centre
Winnipeg, Manitoba, Canada
Grace Hospital
Winnipeg, Manitoba, Canada
Queen Elizabeth II Health Sciences Center
Halifax, Nova Scotia, Canada
Kingston General Hospital
Kingston, Ontario, Canada
Windsor Regional Hospital
Windsor, Ontario, Canada
SMBD - Jewish General Hospital
Montreal, Quebec, Canada
Aalborg Sygehus
Aalborg, , Denmark
Odense universitetshospital
Odense, , Denmark
Hôpital Universitaire Dupuytren
Limoges, Limoges, France
Hôtel Dieu
Angers, , France
Centre Hospitalier Victor Dupouy
Argenteuil, , France
Centre Hospitalier Départemental La Roche sur Yon, Luçon, Montaigu - Les Oudaries
La Roche-sur-Yon, , France
Hôpital Albert Michallon / La Tronche
La Tronche, , France
Centre Hospitalier de Montauban
Montauban, , France
Hôpital de la Source
Orléans, , France
Hôpital Cochin
Paris, , France
Centre Hospitalier Lyon Sud
Pierre-Bénite, , France
Hôpital de la Miletrie
Poitiers, , France
Centre Hospitalier Angouleme
Saint-Michel, , France
Hôpital Bretonneau
Tours, , France
Charité - Universitätsmedizin Berlin
Berlin, , Germany
Universitätsklinikum Bonn
Bonn, , Germany
Helios Klinikum Erfurt
Erfurt, , Germany
Klinikum der Johann-Wolfgang Goethe-Universität
Frankfurt am Main, , Germany
Klinikum der Friedrich-Schiller-Universität Jena
Jena, , Germany
Klinikum der Stadt Ludwigshafen gGmbH
Ludwigshafen, , Germany
Klinikum Harlaching
München, , Germany
Rambam Medical Center
Haifa, , Israel
The Lady Davis Carmel Medical Center
Haifa, , Israel
Shaare Zedek Medical Center
Jerusalem, , Israel
Hadassah University Hospital Ein Kerem
Jerusalem, , Israel
Western Galilee Hospital - Nahariya
Nahariya, , Israel
Rabin Medical Center
Petah Tikva, , Israel
Jeroen Bosch Ziekenhuis
's-Hertogenbosch, , Netherlands
VU Medisch Centrum
Amsterdam, , Netherlands
Gelre Ziekenhuizen
Apeldoorn, , Netherlands
Medisch Centrum Leeuwarden
Leeuwarden, , Netherlands
UMC St. Radboud
Nijmegen, , Netherlands
Ikazia Ziekenhuis
Rotterdam, , Netherlands
Hospital del Mar
Barcelona, Catalonia, Spain
Hospital Universitari De Bellvitge
L'Hospitalet de Llobregat, Catalonia, Spain
Hospital de Sabadell
Sabadell, Catalonia, Spain
Hospital Universitari de Tarragona Joan XXIII
Tarragona, Catalonia, Spain
Hospital Mutua de Terrassa
Terrassa, Catalonia, Spain
Hospital Clinico San Carlos
Madrid, Madrid, Communidad de, Spain
Hospital Universitario La Paz
Madrid, Madrid, Communidad de, Spain
Hospital Universitario de Getafe
Getafe, , Spain
Hospital Universitario La Paz
Madrid, , Spain
Aberdeen Royal Infirmary
Aberdeen, , United Kingdom
St James's University Hospital
Leeds, , United Kingdom
St John's Hospital
Livingston, , United Kingdom
University College London
London, , United Kingdom
St. Thomas' Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Vincent JL, Marshall JC, Dellinger RP, Simonson SG, Guntupalli K, Levy MM, Singer M, Malik R; Oral tAlactoferrin in Severe sepsIS Study Investigators. Talactoferrin in Severe Sepsis: Results From the Phase II/III Oral tAlactoferrin in Severe sepsIS Trial. Crit Care Med. 2015 Sep;43(9):1832-8. doi: 10.1097/CCM.0000000000001090.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LF-0802
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.